291 related articles for article (PubMed ID: 36401978)
1. Exosomal long noncoding RNAs MAGI2-AS3 and CCDC144NL-AS1 in oral squamous cell carcinoma development via the PI3K-AKT-mTOR signaling pathway.
Li C; Guo H; Xiong J; Feng B; Zhu P; Jiang W; Jiang P; Su X; Huang X
Pathol Res Pract; 2022 Dec; 240():154219. PubMed ID: 36401978
[TBL] [Abstract][Full Text] [Related]
2. LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185-5p/PLOD1/Akt/mTOR pathway.
Liu J; Zhang Y; Wu J; Liu X; Li L; Zhang J
Cancer Genet; 2024 Jun; 284-285():48-57. PubMed ID: 38729078
[TBL] [Abstract][Full Text] [Related]
3. Hypermethylation-Mediated lncRNA MAGI2-AS3 Downregulation Facilitates Malignant Progression of Laryngeal Squamous Cell Carcinoma via Interacting With SPT6.
Wang J; Yang C; Cao H; Yang J; Meng W; Yu M; Yu L; Wang B
Cell Transplant; 2023; 32():9636897231154574. PubMed ID: 36852700
[TBL] [Abstract][Full Text] [Related]
4. Long Noncoding RNA LEMD1-AS1 Increases LEMD1 Expression and Activates PI3K-AKT Pathway to Promote Metastasis in Oral Squamous Cell Carcinoma.
Li Z; Wang J; Wu J; Li N; Jiang C
Biomed Res Int; 2022; 2022():3543948. PubMed ID: 35983249
[TBL] [Abstract][Full Text] [Related]
5. Roles of lncRNA MAGI2-AS3 in human cancers.
Kai-Xin L; Cheng C; Rui L; Zheng-Wei S; Wen-Wen T; Peng X
Biomed Pharmacother; 2021 Sep; 141():111812. PubMed ID: 34126355
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MAGI2-AS3 inhibites tumor progression by up-regulating STAM via interacting with miR-142-3p in clear cell renal cell carcinoma.
Yang R; Chen Z; Ao S; Liang L; Chen Z; Duan X; Zeng G; Deng T
Cell Signal; 2024 Jan; 113():110954. PubMed ID: 38084836
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the expression level of some coding and non-coding genes in oral squamous cell carcinoma.
Ajorlou M; Bina-Jourshari P; Mirzaei S; Maghsoudloo M; Hashemi M; Mousavi-Niri N; Entezari M
Mol Cell Probes; 2023 Aug; 70():101916. PubMed ID: 37355145
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
[TBL] [Abstract][Full Text] [Related]
9. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
Hussain SA; Venkatesh T
Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA TFAP2A-AS1 promotes oral squamous cell carcinoma cell growth and movement via competitively binding miR-1297 and regulating TFAP2A expression.
Yang K; Niu Y; Cui Z; Jin L; Peng S; Dong Z
Mol Carcinog; 2022 Sep; 61(9):865-875. PubMed ID: 35730908
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MAGI2-AS3-Encoded Polypeptide Restrains the Proliferation and Migration of Breast Cancer Cells.
Zhang Z; Yi Y; Wang Z; Zhang H; Zhao Y; He R; Luo Y; Cui Z
Mol Biotechnol; 2024 Jun; 66(6):1409-1423. PubMed ID: 37358745
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
Liu M; Gao X; Liu CL
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
[TBL] [Abstract][Full Text] [Related]
14. MAGI2-AS3 and miR-374b-5p as Putative Regulators of Multiple Sclerosis via Modulating the PTEN/AKT/IRF-3/IFN-β Axis: New Clinical Insights.
Kortam MA; Elfar N; Shaker OG; El-Boghdady NA; Abd-Elmawla MA
ACS Chem Neurosci; 2023 Mar; 14(6):1107-1118. PubMed ID: 36878000
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SLC16A1-AS1: its multiple tumorigenesis features and regulatory role in cell cycle in oral squamous cell carcinoma.
Feng H; Zhang X; Lai W; Wang J
Cell Cycle; 2020 Jul; 19(13):1641-1653. PubMed ID: 32450050
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MAGI2-AS3 inhibits bladder cancer progression by targeting the miR-31-5p/TNS1 axis.
Tang C; Cai Y; Jiang H; Lv Z; Yang C; Xu H; Li Z; Li Y
Aging (Albany NY); 2020 Nov; 12(24):25547-25563. PubMed ID: 33231563
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNAs PTENP1, GNG12-AS1, MAGI2-AS3 and MEG3 as tumor suppressors in breast cancer and their associations with clinicopathological parameters.
Záveský L; Jandáková E; Weinberger V; Minář L; Kohoutová M; Slanař O
Cancer Biomark; 2024; 40(1):61-78. PubMed ID: 38277283
[TBL] [Abstract][Full Text] [Related]
18. lncRNA MAGI2-AS3 suppresses castration-resistant prostate cancer proliferation and migration via the miR-106a-5p/RAB31 axis.
Yang G; Li T; Liu J; Quan Z; Liu M; Guo Y; Wu Y; Ou L; Wu X; Zheng Y
Genomics; 2023 Mar; 115(2):110599. PubMed ID: 36889366
[TBL] [Abstract][Full Text] [Related]
19. LAMC2 regulates proliferation, migration, and invasion mediated by the Pl3K/AKT/mTOR pathway in oral.
Shan F; Liang L; Feng C; Xu H; Wang Z; Liu W; Pu L; Chen Z; Chen G; Wang X
Oncol Res; 2023; 31(4):481-493. PubMed ID: 37415741
[TBL] [Abstract][Full Text] [Related]
20. Targeting MAGI2-AS3-modulated Akt-dependent ATP-binding cassette transporters as a possible strategy to reverse temozolomide resistance in temozolomide-resistant glioblastoma cells.
Chen Z; Zhou J; Liu Y; Ni H; Zhou B
Drug Dev Res; 2023 Nov; 84(7):1482-1495. PubMed ID: 37551766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]